Brief: Genscript Biotech Says Committee For Medicinal Products Human Use Of European Medicines Agency Recommended Marketing Authorization Of Carvykti
25/03/2022 15:30
March 25 (Reuters) - Genscript Biotech:
* COMMITTEE FOR MEDICINAL PRODUCTS HUMAN USE OF EUROPEAN
MEDICINES
AGENCY RECOMMENDED MARKETING AUTHORIZATION OF CARVYKTI
Source text for Eikon: ID:nHKS3zRlRh
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale